Lumacaftor/Ivacaftor-Orkambi-Vertex-Cystic Fibrosis

Publication reference: 2021/S 000-002921
Publication date: 12 February 2021

F03: Contract award notice

Section one: Contracting authority

one.1) Name and addresses

BELFAST HEALTH AND SOCIAL CARE TRUST

LISBURN ROAD

BELFAST

BT97AB

Contact

Norma Moore

Email

norma.moore@belfasttrust.hscni.net

Country

United Kingdom

NUTS code

UKN0 - Northern Ireland

Internet address(es)
Main address

www.belfasttrust.hscni.net

one.4) Type of the contracting authority

Body governed by public law

one.5) Main activity

Health


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

Lumacaftor/Ivacaftor-Orkambi-Vertex-Cystic Fibrosis

Reference number

DACPM2021-03

two.1.2) Main CPV code
  • 33000000 - Medical equipments, pharmaceuticals and personal care products
two.1.3) Type of contract

Supplies

two.1.4) Short description

Lumacaftor/Ivacaftor-Orkambi-Vertex-Cystic Fibrosis

two.1.6) Information about lots

This contract is divided into lots: No

two.1.7) Total value of the procurement (excluding VAT)

Value excluding VAT: £1,500,000

two.2) Description

two.2.2) Additional CPV code(s)
  • 33000000 - Medical equipments, pharmaceuticals and personal care products
two.2.3) Place of performance
NUTS codes
  • UKN - NORTHERN IRELAND
two.2.4) Description of the procurement

Lumacaftor/Ivacaftor-Orkambi-Vertex-Cystic Fibrosis

two.2.5) Award criteria

Price

two.2.11) Information about options

Options: No


Section four. Procedure

four.1) Description

four.1.1) Type of procedure

Award of a contract without prior publication of a call for competition in the cases listed below

  • The services can be provided only by a particular economic operator for the following reason:
    • protection of exclusive rights, including intellectual property rights

Explanation:

This a patent protected medicine available from only one economic operator, Vertex Pharmaceuticals Europe Ltd

four.1.8) Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes


Section five. Award of contract

Contract No

DACPM2021-03

Title

Lumacaftor/Ivacaftor-Orkambi-Vertex-Cystic Fibrosis

A contract/lot is awarded: Yes

five.2) Award of contract

five.2.1) Date of conclusion of the contract

3 February 2021

five.2.2) Information about tenders

Number of tenders received: 1

The contract has been awarded to a group of economic operators: No

five.2.3) Name and address of the contractor

Vertex Pharmaceuticals Europe Ltd

2 Kingdom Street

London

W2 6BD

Country

United Kingdom

NUTS code
  • UKI - LONDON
The contractor is an SME

No

five.2.4) Information on value of contract/lot (excluding VAT)

Initial estimated total value of the contract/lot: £1,500,000

Total value of the contract/lot: £1,500,000


Section six. Complementary information

six.4) Procedures for review

six.4.1) Review body

Belfast Health & Social Care Trust

Lisburn Road

Belfast

BT9 7AB

Country

United Kingdom